Back to DE Deerfield Management Company, L.P.
SPRY
Showing 8 of 16 quarters
Position history for DEDeerfield Management Company, L.P.'s holdings in ARS Pharmaceuticals, Inc.
Yes. Deerfield Management holds 7,503,812 shares of SPRY (ARS Pharmaceuticals), worth $32.3M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Deerfield Management has held SPRY since Q4 2022, across 16 quarterly 13F filings. SPRY is 0.5% of Deerfield Management's reported 13F portfolio.
Current Value
$32.3M
Current Shares
7.5M
Total Value Change
-$78.6M
Total Shares Change
-3M
Quarter-by-Quarter History